The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Rui Zhao, Yin Yang, Ganggang Shi et al.|International Journal of Radiation Oncology*Biology*Physics|2023

Cited by 0